Global and Region Huntington Disease Protein Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Huntington Disease Protein market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Huntington Disease Proteinmarket, defines the market attractiveness level of Huntington Disease Protein market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Huntington Disease Protein industry, describes the types of Huntington Disease Protein market, the applications of major players and the market size, and deeply analyzes the current situation of the global Huntington Disease Protein market and the development prospects and opportunities of Huntington Disease Protein industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Huntington Disease Protein market in Chapter 13.

    By Player:

    • Ionis Pharmaceuticals, Inc

    • Sangamo BioSciences, Inc

    • AFFiRiS AG

    • Neurimmune Holding AG

    • Voyager Therapeutics, Inc

    • Vybion, Inc

    • reMYND NV

    • nLife Therapeutics, SL

    • WAVE Life Sciences Ltd

    • UniQure NV

    By Type:

    • NI-302

    • NLF-HD

    • P-301905

    • IONIS-HTTRx

    • Others

    By End-User:

    • Alzheimer's Disease

    • Kennedy's Disease

    • Spinocerebellar Ataxia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Huntington Disease Protein Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Huntington Disease Protein Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Huntington Disease Protein Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Huntington Disease Protein Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Huntington Disease Protein Market Analysis and Outlook to 2022

    • 7.1 Global Huntington Disease Protein Consumption (2017-2022)

    • 7.2 United States Huntington Disease Protein Consumption (2017-2022)

    • 7.3 Europe Huntington Disease Protein Consumption (2017-2022)

    • 7.4 China Huntington Disease Protein Consumption (2017-2022)

    • 7.5 Japan Huntington Disease Protein Consumption (2017-2022)

    • 7.6 India Huntington Disease Protein Consumption (2017-2022)

    • 7.7 South Korea Huntington Disease Protein Consumption (2017-2022)

    8 Region and Country-wise Huntington Disease Protein Market Analysis and Outlook to 2028

    • 8.1 Global Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.2 United States Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.3 Europe Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.4 China Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.5 Japan Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.6 India Huntington Disease Protein Consumption Forecast (2022-2028)

    • 8.7 South Korea Huntington Disease Protein Consumption Forecast (2022-2028)

    9 Global Huntington Disease Protein Market Outlook by Types and Applications to 2022

    • 9.1 Global Huntington Disease Protein Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global NI-302 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global NLF-HD Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global P-301905 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global IONIS-HTTRx Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Huntington Disease Protein Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Kennedy's Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Spinocerebellar Ataxia Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Huntington Disease Protein Market Outlook by Types and Applications to 2028

    • 10.1 Global Huntington Disease Protein Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global NI-302 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global NLF-HD Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global P-301905 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global IONIS-HTTRx Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Huntington Disease Protein Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Kennedy's Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Spinocerebellar Ataxia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Huntington Disease Protein Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Huntington Disease Protein Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Huntington Disease Protein Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Huntington Disease Protein Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Huntington Disease Protein Market Competitive Analysis

    • 14.1 Ionis Pharmaceuticals, Inc

      • 14.1.1 Ionis Pharmaceuticals, Inc Company Details

      • 14.1.2 Ionis Pharmaceuticals, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Ionis Pharmaceuticals, Inc Huntington Disease Protein Product and Service

    • 14.2 Sangamo BioSciences, Inc

      • 14.2.1 Sangamo BioSciences, Inc Company Details

      • 14.2.2 Sangamo BioSciences, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sangamo BioSciences, Inc Huntington Disease Protein Product and Service

    • 14.3 AFFiRiS AG

      • 14.3.1 AFFiRiS AG Company Details

      • 14.3.2 AFFiRiS AG Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AFFiRiS AG Huntington Disease Protein Product and Service

    • 14.4 Neurimmune Holding AG

      • 14.4.1 Neurimmune Holding AG Company Details

      • 14.4.2 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Neurimmune Holding AG Huntington Disease Protein Product and Service

    • 14.5 Voyager Therapeutics, Inc

      • 14.5.1 Voyager Therapeutics, Inc Company Details

      • 14.5.2 Voyager Therapeutics, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Voyager Therapeutics, Inc Huntington Disease Protein Product and Service

    • 14.6 Vybion, Inc

      • 14.6.1 Vybion, Inc Company Details

      • 14.6.2 Vybion, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Vybion, Inc Huntington Disease Protein Product and Service

    • 14.7 reMYND NV

      • 14.7.1 reMYND NV Company Details

      • 14.7.2 reMYND NV Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 reMYND NV Huntington Disease Protein Product and Service

    • 14.8 nLife Therapeutics, SL

      • 14.8.1 nLife Therapeutics, SL Company Details

      • 14.8.2 nLife Therapeutics, SL Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 nLife Therapeutics, SL Huntington Disease Protein Product and Service

    • 14.9 WAVE Life Sciences Ltd

      • 14.9.1 WAVE Life Sciences Ltd Company Details

      • 14.9.2 WAVE Life Sciences Ltd Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 WAVE Life Sciences Ltd Huntington Disease Protein Product and Service

    • 14.10 UniQure NV

      • 14.10.1 UniQure NV Company Details

      • 14.10.2 UniQure NV Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 UniQure NV Huntington Disease Protein Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Huntington Disease Protein

    • Figure Huntington Disease Protein Picture

    • Table Global Huntington Disease Protein Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Huntington Disease Protein Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Huntington Disease Protein Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Huntington Disease Protein Consumption by Country (2017-2022)

    • Figure United States Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Table Europe Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Figure China Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Figure Japan Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Figure India Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Figure South Korea Huntington Disease Protein Consumption and Growth Rate (2017-2022)

    • Figure Global Huntington Disease Protein Consumption Forecast by Country (2022-2028)

    • Figure United States Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Huntington Disease Protein Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NI-302 Consumption and Growth Rate (2017-2022)

    • Figure Global NLF-HD Consumption and Growth Rate (2017-2022)

    • Figure Global P-301905 Consumption and Growth Rate (2017-2022)

    • Figure Global IONIS-HTTRx Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Kennedy's Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Spinocerebellar Ataxia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global NI-302 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NLF-HD Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global P-301905 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IONIS-HTTRx Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kennedy's Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Spinocerebellar Ataxia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Huntington Disease Protein Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Huntington Disease Protein Export by Region (Top 5 Countries) (2017-2028)

    • Table Ionis Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Ionis Pharmaceuticals, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ionis Pharmaceuticals, Inc Huntington Disease Protein Product and Service

    • Table Sangamo BioSciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Sangamo BioSciences, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo BioSciences, Inc Huntington Disease Protein Product and Service

    • Table AFFiRiS AG (Foundation Year, Company Profile and etc.)

    • Table AFFiRiS AG Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table AFFiRiS AG Huntington Disease Protein Product and Service

    • Table Neurimmune Holding AG (Foundation Year, Company Profile and etc.)

    • Table Neurimmune Holding AG Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurimmune Holding AG Huntington Disease Protein Product and Service

    • Table Voyager Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Voyager Therapeutics, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Voyager Therapeutics, Inc Huntington Disease Protein Product and Service

    • Table Vybion, Inc (Foundation Year, Company Profile and etc.)

    • Table Vybion, Inc Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vybion, Inc Huntington Disease Protein Product and Service

    • Table reMYND NV (Foundation Year, Company Profile and etc.)

    • Table reMYND NV Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table reMYND NV Huntington Disease Protein Product and Service

    • Table nLife Therapeutics, SL (Foundation Year, Company Profile and etc.)

    • Table nLife Therapeutics, SL Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table nLife Therapeutics, SL Huntington Disease Protein Product and Service

    • Table WAVE Life Sciences Ltd (Foundation Year, Company Profile and etc.)

    • Table WAVE Life Sciences Ltd Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table WAVE Life Sciences Ltd Huntington Disease Protein Product and Service

    • Table UniQure NV (Foundation Year, Company Profile and etc.)

    • Table UniQure NV Huntington Disease Protein Sales, Price, Value and Gross Profit (2017-2022)

    • Table UniQure NV Huntington Disease Protein Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.